Positioning new treatments in the management of immune thrombocytopenia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Positioning new treatments in the management of immune thrombocytopenia
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 60, Issue S1, Pages S19-S22
Publisher
Wiley
Online
2012-10-25
DOI
10.1002/pbc.24341
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk for Hospital Contact With Infection in Patients With Splenectomy
- (2013) Reimar W. Thomsen ANNALS OF INTERNAL MEDICINE
- Prevalence of primary immune thrombocytopenia in Oklahoma
- (2012) Deirdra R. Terrell et al. AMERICAN JOURNAL OF HEMATOLOGY
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
- (2012) D. M. Arnold et al. BLOOD
- Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
- (2012) V. L. Patel et al. BLOOD
- Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis
- (2012) Sophie Auger et al. BRITISH JOURNAL OF HAEMATOLOGY
- Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy
- (2012) Karen K. W. Wang et al. HEALTH EXPECTATIONS
- Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
- (2012) Nezam H. Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia
- (2011) J. B. Bussel et al. BLOOD
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
- (2011) C. Neunert et al. BLOOD
- Standard-dose Intravenous Anti-D Immunoglobulin Versus Intravenous Immunoglobulin in the Treatment of Newly Diagnosed Childhood Primary Immune Thrombocytopenia
- (2011) Andromachi Papagianni et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
- (2010) F. Zaja et al. BLOOD
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
- (2010) W. Bao et al. BLOOD
- Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)
- (2010) T. B. GERNSHEIMER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
- (2010) Gregory Cheng et al. LANCET
- Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
- (2010) David J. Kuter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
- (2009) D. J. Kuter et al. BLOOD
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses
- (2009) Donald M Arnold et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
- (2009) Hagop Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started